Serina Therapeutics (SER) Other Gross PP&E Adjustments (2017 - 2025)
Serina Therapeutics' Other Gross PP&E Adjustments history spans 8 years, with the latest figure at $918000.0 for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 109.59% year-over-year to $918000.0; the TTM value through Sep 2025 reached $918000.0, up 109.59%, while the annual FY2024 figure was $83000.0, 72.05% down from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was $918000.0 at Serina Therapeutics, up from $860000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $1.0 million in Q1 2025 and bottomed at -$690000.0 in Q4 2021.
- The 5-year median for Other Gross PP&E Adjustments is $25500.0 (2022), against an average of $184000.0.
- The largest YoY upside for Other Gross PP&E Adjustments was 1427.27% in 2024 against a maximum downside of 72.05% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$690000.0 in 2021, then rose by 6.81% to -$643000.0 in 2022, then soared by 146.19% to $297000.0 in 2023, then crashed by 72.05% to $83000.0 in 2024, then skyrocketed by 1006.02% to $918000.0 in 2025.
- Per Business Quant, the three most recent readings for SER's Other Gross PP&E Adjustments are $918000.0 (Q3 2025), $860000.0 (Q2 2025), and $1.0 million (Q1 2025).